RCUS

NYSEStock

Arcus Biosciences, Inc.

$21.83-0.87 (-3.83%)

52-Week Range

$6.87

$26.10

Key Stats

Market Cap

2.2B

P/E Ratio

—

Dividend Yield

—

Beta

0.92

Volume

772.7K

Avg Volume

1.4M

Performance

+13.73%

+3.61%

+96.03%

YTD

-2.53%

+143.04%

+33.84%

-35.68%

Price Chart

ETF Exposure

RCUS is held by 131 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	13,213	$376K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,139	$32K	$1.29B	0.17%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	5,201,224	$125K	$3.91B	0.07%
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.00%	9,675	$220K	$11.88B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.00%	6,292	$132K	$5.50B	0.06%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	118,651	$227K	$14.63B	0.20%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	1,918	$47K	$2.84B	0.19%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	1,671	$41K	$3.23B	0.20%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	11,166	$253K	$40.55B	0.17%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	37	$907	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	43	$1K	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	51	$1K	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	42	$1K	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	28	$679	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	21	$513	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	9	$228	$9.3M	0.12%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	4,412	$126K	$12.17B	0.24%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	189	$5K	$725.0M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	578	$14K	$1.67B	0.20%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	66	$2K	$803.1M	0.23%
IMID.L	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	800	$15K	$5.16B	0.17%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	7	$161	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	22	$533	$80.3M	0.10%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,208	$26K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,208	$26K	$6.3M	0.60%
SPYI.DE	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	800	$13K	$4.48B	0.17%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,208	$26K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	123	$4K	$820.6M	0.25%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,208	$26K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,208	$26K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	21	$608	$337.7M	0.32%

PreviousPage 3 of 3

About RCUS ETF Exposure

Arcus Biosciences, Inc. (RCUS) is held by 131 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.2B, RCUS is a widely held institutional stock. The stock currently trades at $21.83. Investors can gain exposure to RCUS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RCUS, sorted by portfolio weight.